期刊文献+

循环肿瘤细胞与鼻咽癌临床病理参数的相关性研究 被引量:9

Correlation of circulating tumor cells with clinicopathological parameters in patients with nasopharyngeal carcinoma
下载PDF
导出
摘要 目的分析外周血循环肿瘤细胞与鼻咽癌临床病理参数的相关性,探讨其临床意义。方法采用莱尔生物循环肿瘤细胞检测技术检测循环肿瘤细胞在63例初治鼻咽癌和20例正常人中的表达情况,分析循环肿瘤细胞的表达差异及与临床病理参数的关系。结果鼻咽癌患者中循环肿瘤细胞阳性率为55.6%,而正常人中循环肿瘤细胞阳性率为0,两者差异有统计学意义(x2=19.213,P<0.05)。在M0期和M1期患者中,循环肿瘤细胞阳性率分别为48.1%和90.9%,差异有统计学意义(x2=6.746,P<0.05)。在EBV-DNA阴性的鼻咽癌患者中,循环肿瘤细胞阳性率为45.5%,而在EBV-DNA阳性的患者中阳性率为78.9%,两者差异有统计学意义(x2=6.029,P<0.05)。性别、年龄、病理类型、T分期、N分期、总分期和VCA-Ig A不同的各组中,循环肿瘤细胞阳性率差异无统计学意义。结论循环肿瘤细胞与鼻咽癌转移和EBV-DNA密切相关,可用于鼻咽癌病情的评价。 Objective To analyze the correlation of circulating tumor cells(CTCs)with clinicopathological parameters in patients with nasopharyngeal carcinoma(NPC),and explore its clinical significance. Methods CTCs were detected in 63 non-treated NPC patients and 20 normal people using CyttelBio CTC detection technology.The differential expression of CTCs and relationship between CTCs and clinicopathological parameters were analyzed. Results The positive rate of CTCs in NPC patients was 55.6%,while it is 0 in normal people,and the difference was statistically significant(x2=19.213,P 〈 0.05).In M0 and M1 NPC patients,the positive rate of CTCs was 48.1% and 90.9% respectively,with significant difference (x2=6.746,P 〈 0.05).In NPC patients with negativeEBV-DNA,the positive rate of CTCs was 45.5%,while in patients withpositive EBV-DNA,the rate was 78.9%,and the difference was statistically significant(x2=6.029,P 〈 0.05).In groups with differentgender,age,histological type,T stage,N stage,overall stage or VCA-IgA,the positive rates of CTCs had no significant difference. Conclusion CTCs are closely correlated with NPC metastasis and EBV-DNA,and can be used to evaluate NPC.
出处 《中国医药科学》 2015年第9期17-19,98,共4页 China Medicine And Pharmacy
关键词 循环肿瘤细胞 鼻咽癌 临床病理参数 Circulating tumor cells Nasopharyngeal carcinoma Clinicopathological parameters
  • 相关文献

参考文献19

  • 1Attard G,De Bono JS.Utilizing circulating tumor cells:challenges and pitfalls[J].Curr Opin Genet Dev,2011,21(1):50-58.
  • 2Kim MY,Oskarsson T,Acharyya S,et al.Tumor selfseeding by circulating cancer cells[J].Cell,2009,139(7):1315-1326.
  • 3Ross JS,Slodkowska EA.Circulating and disseminated tumor cells in the management of breast cancer[J].Am J Clin Pathol,2009,132(2):237-245.
  • 4Dorsey JF,Kao GD,Mac Arthur KM,et al.Tracking viable circulating tumor cells(CTCs)in the peripheral blood of non-small cell lung cancer(NSCLC)patients undergoing definitive radiation therapy:pilot study results[J].Cancer,2015,121(1):139-149.
  • 5Mego M,Giordano A,De Giorgi U,et al.Circulating tumor cells in newly diagnosed inflammatory breast cancer[J].Breast Cancer Res,2015,17(1):2.
  • 6van Dalum G,Stam GJ,Scholten LF,et al.Importance of circulating tumor cells in newly diagnosed colorectal cancer[J].Int J Oncol,2015,46(3):1361-1368.
  • 7Huang X,Gao P,Sun J,et al.Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer:a meta-analysis[J].Int J Cancer,2015,136(1):21-33.
  • 8Zhang Y,Wang F,Ning N,et al.Patterns of circulating tumor cells identified by CEP8,CK and CD45 in pancreatic cancer[J].Int J Cancer,2015,136(5):1228-1233.
  • 9King JD,Casavant BP,Lang JM.Rapid translation of circulating tumor cell biomarkers into clinical practice:technology development,clinical needs and regulatory requirements[J].Lab Chip,2014,14(1):24-31.
  • 10潘建基.鼻咽癌’92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-6. 被引量:261

二级参考文献87

共引文献301

同被引文献65

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部